Current and Future Bioanalytical Approaches for Stroke Assessment

References

• Hatano S . Experience from a multicentre stroke register: a preliminary report. Bull. World Health Organ. 54 (5), 541–553 (1976).
   PubMed Web of Science ®Google Scholar
• Sacco RL , KasnerSE, BroderickJPet al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke44 (7), 2064–2089 (2013).
   PubMed Web of Science ®Google Scholar
• Saenger AK , ChristensonRH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin. Chem. 56, 21–33 (2010).
   PubMed Web of Science ®Google Scholar
• Schwamm LH , PancioliA, AckerJE3rdet al. Recommendations for the establishment of stroke systems of care: recommendations from the American Stroke Association’s Task Force on the Development of Stroke Systems. Stroke36 (3), 690–703 (2005).
   PubMed Web of Science ®Google Scholar
• Di CA , BaldereschiM, GandolfoCet al. Stroke in an elderly population: incidence and impact on survival and daily function: the Italian Longitudinal Study on Aging. Cerebrovasc. Dis. 16 (2), 141–150 (2003).
   PubMed Web of Science ®Google Scholar
• Ma VY , ChanL, CarruthersKJ. Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and back pain. Arch. Phys. Med. Rehabil. 95 (5), 986–995.e1 (2014).
   PubMed Web of Science ®Google Scholar
• Gorelick PB , SaccoRL, SmithDBet al. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA281 (12), 1112–1120 (1999).
   PubMed Web of Science ®Google Scholar
• Alila Medical Media . www.alilamedicalmedia.com.
   Google Scholar
• Go AS , MozaffarianD, RogerVLet al. Executive summary: Heart Disease and Stroke Statistics – 2014 update: a report from the American Heart Association. Circulation129 (3), 399–410 (2014).
   PubMed Web of Science ®Google Scholar
• Adams HP Jr. , BendixenBH, KappelleLJet al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke24 (1), 35–41 (1993).
   PubMed Web of Science ®Google Scholar
• Dirnagl U , IadecolaC, MoskowitzMA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (9), 391–397 (1999).
   PubMed Web of Science ®Google Scholar
• Fisher M , GarciaJH. Evolving stroke and the ischemic penumbra. Neurology47 (4), 884–888 (1996).
   PubMed Web of Science ®Google Scholar
• Green AR , ShuaibA. Therapeutic strategies for the treatment of stroke. Drug Discov. Today11 (15–16), 681–693 (2006).
   PubMed Web of Science ®Google Scholar
• Litchfield WR , AndersonBF, WeissRJ, LiftonRP, DluhyRG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension31 (1 Pt 2), 445–450 (1998).
   PubMed Web of Science ®Google Scholar
• Ustrell-Roig X , Serena-LealJ. Stroke: diagnosis and therapeutic management of cerebrovascular disease. Rev. Esp. Cardiol. 60 (7), 753–769 (2007).
   PubMed Web of Science ®Google Scholar
• Andersen KK , OlsenTS, DehlendorffC, KammersgaardLP. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke40, 2068–2072 (2009).
   PubMed Web of Science ®Google Scholar
• Artto V , PutaalaJ, StrbianDet al. Stroke mimics and intravenous thrombolysis. Ann. Emerg. Med. 59 (1), 27–32 (2012).
   PubMed Web of Science ®Google Scholar
• Hemmen TM , MeyerBC, McCleanTL, LydenPD. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J. Stroke Cerebrovasc. Dis. 17 (1), 23–25 (2008).
   PubMedGoogle Scholar
• Brunser AM , IllanesS, LavadosPMet al. Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study. J. Stroke Cerebrovasc. Dis. 22 (7), 1140–1145 (2012).
   PubMed Web of Science ®Google Scholar
• Guillan M , Alonso-CanovasA, Gonzalez-ValcarcelJet al. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovasc. Dis. 34 (2), 115–120 (2012).
   PubMed Web of Science ®Google Scholar
• Norris JW , HachinskiVC. Misdiagnosis of stroke. Lancet1, 328–331 (1982).
   PubMed Web of Science ®Google Scholar
• McKeith IG . Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J. Alzheimers Dis. 9 (3 Suppl.), 417–423 (2006).
   PubMedGoogle Scholar
• Fisher CM , AdamsRD. Transient global amnesia. Acta Neurol. Scand. Suppl. 40 (Suppl. 9), 1–83 (1964).
   Google Scholar
• Hand PJ , KwanJ, LindleyRI, DennisMS, WardlawJM. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke37 (3), 769–775 (2006).
   PubMed Web of Science ®Google Scholar
• Libman RB , WirkowskiE, AlvirJ, RaoTH. Conditions that mimic stroke in the emergency department: implications for acute stroke trials. Arch. Neurol. 52 (11), 1119–1122 (1995).
   PubMedGoogle Scholar
• Johnston SC , GressDR, BrownerWS, SidneyS. Short-term prognosis after emergency department diagnosis of TIA. JAMA284 (22), 2901–2906 (2000).
   PubMed Web of Science ®Google Scholar
• Lyden PD , HantsonL. Assessment scales for the evaluation of stroke patients. J. Stroke Cerebrovasc. Dis. 7 (2), 113–127 (1998).
   PubMedGoogle Scholar
• Spence JD , DonnerA. Problems in design of stroke treatment trials. Stroke13 (1), 94–99 (1982).
   PubMed Web of Science ®Google Scholar
• Lyden P , BrottT, TilleyBet al. Improved reliability of the NIH Stroke Scale using video training: NINDS TPA Stroke Study Group. Stroke25 (11), 2220–2226 (1994).
   PubMed Web of Science ®Google Scholar
• Muir KW , WeirCJ, MurrayGD, PoveyC, LeesKR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke27 (10), 1817–1820 (1996).
   PubMed Web of Science ®Google Scholar
• Goldstein LB , BertelsC, DavisJN. Interrater reliability of the NIH stroke scale. Arch. Neurol. 46 (6), 660–662 (1989).
   PubMed Web of Science ®Google Scholar
• Lyden P , ClaessonL, HavstadS, AshwoodT, LuM. Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes. Arch. Neurol. 61 (11), 1677–1680 (2004).
   PubMedGoogle Scholar
• Lyden PD , LuM, LevineSR, BrottTG, BroderickJ. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke32 (6), 1310–1317 (2001).
   PubMed Web of Science ®Google Scholar
• Kasner SE . Clinical interpretation and use of stroke scales. Lancet Neurol. 5 (7), 603–612 (2006).
   PubMed Web of Science ®Google Scholar
• Cavanagh SJ , GordonVL. Grading scales used in the management of aneurysmal subarachnoid hemorrhage: a critical review. J. Neurosci. Nurs. 34 (6), 288–295 (2002).
   PubMedGoogle Scholar
• Nour M , LiebeskindDS. Brain imaging in stroke: insight beyond diagnosis. Neurotherapeutics8, 330–339 (2011).
   PubMed Web of Science ®Google Scholar
• Adams HP Jr. , AdamsRJ, BrottTet al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke34 (4), 1056–1083 (2003).
   PubMed Web of Science ®Google Scholar
• Ezzeddine MA , LevMH, McDonaldCTet al. CT angiography with whole brain perfused blood volume imaging: added clinical value in the assessment of acute stroke. Stroke33 (4), 959–966 (2002).
   PubMed Web of Science ®Google Scholar
• Srinivasan A , GoyalM, AlAF, LumC. State-of-the-art imaging of acute stroke. Radiographics26 (Suppl. 1), S75–S95 (2006).
   PubMedGoogle Scholar
• Mullins ME , SchaeferPW, SorensenAGet al. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology224 (2), 353–360 (2002).
   PubMed Web of Science ®Google Scholar
• Ebinger M , FiebachJB, AudebertHJ. Mobile computed tomography: prehospital diagnosis and treatment of stroke. Curr. Opin. Neurol. 28 (1), 4–9 (2015).
   PubMed Web of Science ®Google Scholar
• Baird AE , WarachS. Magnetic resonance imaging of acute stroke. J. Cereb. Blood Flow Metab. 18 (6), 583–609 (1998).
   PubMed Web of Science ®Google Scholar
• Chalela JA , KidwellCS, NentwichLMet al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet369 (9558), 293–298 (2007).
   PubMed Web of Science ®Google Scholar
• Schellinger PD , JansenO, FiebachJB, HackeW, SartorK. A standardized MRI stroke protocol: comparison with CT in hyperacute intracerebral hemorrhage. Stroke30 (4), 765–768 (1999).
   PubMed Web of Science ®Google Scholar
• Medcalf RL . Plasminogen activation-based thrombolysis for ischaemic stroke: the diversity of targets may demand new approaches. Curr. Drug Targets12, 1772–1781 (2011).
   PubMed Web of Science ®Google Scholar
• Turner RC , Lucke-WoldB, Lucke-WoldNet al. Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions. Int. J. Mol. Sci. 14, 1890–1917 (2013).
   PubMed Web of Science ®Google Scholar
• Hacke W , KasteM, BluhmkiEet al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Hacke W , KasteM, FieschiCet al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke The European Cooperative Acute Stroke Study (ECASS). JAMA274 (13), 1017–1025 (1995).
   PubMed Web of Science ®Google Scholar
• Hacke W , KasteM, FieschiCet al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Lancet352 (9136), 1245–1251 (1998).
   PubMed Web of Science ®Google Scholar
• Clark WM , WissmanS, AlbersGW, JhamandasJH, MaddenKP, HamiltonS. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA282 (21), 2019–2026 (1999).
   PubMed Web of Science ®Google Scholar
• Lees KR , BluhmkiE, von KummerR. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet375, 1695–1703 (2010).
   PubMed Web of Science ®Google Scholar
• Katzan IL , HammerMD, HixsonED, FurlanAJ, Abou-CheblA, NadzamDM. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch. Neurol. 61 (3), 346–350 (2004).
   PubMedGoogle Scholar
• Pereira AC , BrownMM. Aspirin or heparin in acute stroke. Br. Med. Bull. 56 (2), 413–421 (2000).
   PubMed Web of Science ®Google Scholar
• Sherman DG . Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?Cerebrovasc. Dis. 17 (Suppl. 1), 138–143 (2004).
   PubMedGoogle Scholar
• Camerlingo M , SalviP, BelloniG, GambaT, CesanaBM, MamoliA. Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions. Stroke36 (11), 2415–2420 (2005).
   PubMed Web of Science ®Google Scholar
• Berkhemer OA , FransenPSS, BeumerDet al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372 (1), 11–20 (2015).
   PubMed Web of Science ®Google Scholar
• Goyal M , DemchukAM, MenonBKet al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N. Engl. J. Med. ( Epub ahead of print) (2015).
   Web of Science ®Google Scholar
• Campbell BCV , MitchellPJ, KleinigTJet al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. ( Epub ahead of print) (2015).
   Web of Science ®Google Scholar
• Blanchette M , FortinD. Blood-brain barrier disruption in the treatment of brain tumors. Methods Mol. Biol. 686, 447–463 (2011).
   PubMedGoogle Scholar
• Chen Y , LiuL. Modern methods for delivery of drugs across the blood–brain barrier. Adv. Drug Deliv. Rev. 64 (7), 640–665 (2012).
   PubMed Web of Science ®Google Scholar
• Rolls MM , AlbertsonR, ShihH-p, LeeC-y, DoeCQ. Drosophila aPKC regulates cell polarity and cell proliferation in neuroblasts and epithelia. J. Cell Biol. 163 (5), 1089–1098 (2003).
   PubMed Web of Science ®Google Scholar
• Abbott NJ , LarsR, ElisabethH. Astrocyte–endothelial interactions at the blood–brain barrier. Nat. Rev. Neurosc. 7 (1), 41–53 (2006).
   PubMed Web of Science ®Google Scholar
• Ransohoff RM , PerryVH. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119–145 (2009).
   PubMed Web of Science ®Google Scholar
• Nag S , KapadiaA, StewartDJ. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol. Appl. Neurobiol. 37 (1), 3–23 (2011).
   PubMed Web of Science ®Google Scholar
• Papadopoulos MC , SaadounS, DaviesDC, BellBA. Emerging molecular mechanisms of brain tumour oedema. Br. J. Neurosurg. 15 (2), 101–108 (2001).
   PubMed Web of Science ®Google Scholar
• Tsao N , HsuHP, WuCM, LiuCC, LeHY. Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis. J. Med. Microbiol. 50 (9), 812–821 (2001).
   PubMed Web of Science ®Google Scholar
• Hallenbeck JM , DutkaAJ, TanishimaTet al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke17 (2), 246–253 (1986).
   PubMed Web of Science ®Google Scholar
• Chou W-H , ChoiD-S, ZhangHet al. Neutrophil protein kinase Cδ as a mediator of stroke-reperfusion injury. J. Clin. Invest. 114 (1), 49–56 (2004).
   PubMed Web of Science ®Google Scholar
• Lawrence MB , SpringerTA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell65 (5), 859–873 (1991).
   PubMed Web of Science ®Google Scholar
• Justicia C , PanesJ, SoleSet al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J. Cereb. Blood Flow Metab. 23 (12), 1430–1440 (2003).
   PubMed Web of Science ®Google Scholar
• Seo JH , GuoS, LokJet al. Neurovascular matrix metalloproteinases and the blood-brain barrier. Curr. Pharm. Des. 18, 3645–3648 (2012).
   PubMed Web of Science ®Google Scholar
• Rifai N , GilletteMA, CarrSA. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24 (8), 971–983 (2006).
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group . Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69 (3), 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Naylor S . Biomarkers: current perspectives and future prospects. Expert Rev. Mol. Diagn. 3 (5), 525–529 (2003).
   PubMed Web of Science ®Google Scholar
• Gibler WB , BlomkalnsAL, CollinsSP. Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide. Rev. Cardiovasc. Med. 4 (Suppl. 4), S47–S55 (2003).
   PubMedGoogle Scholar
• Penttila K , KoukkunenH, HalinenMet al. Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. Clin. Biochem. 35 (8), 647–653 (2002).
   PubMed Web of Science ®Google Scholar
• Stein PD , HullRD, PatelKCet al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann. Intern. Med. 140 (8), 589–602 (2004).
   PubMed Web of Science ®Google Scholar
• Ge S , SongL, PachterJS. Where is the blood-brain barrier… really?J. Neurosci. Res. 79 (4), 421–427 (2005).
   PubMed Web of Science ®Google Scholar
• Reynolds MA , KirchickHJ, DahlenJRet al. Early biomarkers of stroke. Clin. Chem. 49, 1733–1739 (2003).
   PubMed Web of Science ®Google Scholar
• Craig-Schapiro R , FaganAM, HoltzmanDM. Biomarkers of Alzheimer’s disease. Neurobiol. Dis. 35 (2), 128–140 (2009).
   PubMed Web of Science ®Google Scholar
• Yoon CW , KimSJ, BangOY, ChungCS, LeeKH, KimGM. Premorbid warfarin use and lower D-dimer levels are associated with a spontaneous early improvement in an atrial fibrillation-related stroke. J. Thromb. Haemost. 10 (11), 2394–2396 (2012).
   PubMed Web of Science ®Google Scholar
• Motoki H , TomitaT, AizawaKet al. Coagulation activity is increased in the left atria of patients with paroxysmal atrial fibrillation during the non-paroxysmal period: comparison with chronic atrial fibrillation. Circ. J73 (8), 1403–1407 (2009).
   PubMed Web of Science ®Google Scholar
• Rothermundt M , PetersM, PrehnJHM, AroltV. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60 (6), 614–632 (2003).
   PubMed Web of Science ®Google Scholar
• Foerch C , WunderlichMT, DvorakFet al. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke38 (9), 2491–2495 (2007).
   PubMed Web of Science ®Google Scholar
• Delgado P , Alvarez SabinJ, SantamarinaEet al. Plasma S100B level after acute spontaneous intracerebral hemorrhage. Stroke37 (11), 2837–2839 (2006).
   PubMed Web of Science ®Google Scholar
• Missler U , WiesmannM, FriedrichC, KapsM. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke28 (10), 1956–1960 (1997).
   PubMed Web of Science ®Google Scholar
• Marchi N , CavagliaM, FazioV, BhudiaS, HalleneK, JanigroD. Peripheral markers of blood-brain barrier damage. Clin. Chim. Acta342 (1–2), 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Martens P , RaabeA, JohnssonP. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke29 (11), 2363–2366 (1998).
   PubMed Web of Science ®Google Scholar
• Dassan P , KeirG, BrownMM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc. Dis. 27 (3), 295–302 (2009).
   PubMed Web of Science ®Google Scholar
• Pelinka LE , KroepflA, SchmidhammerRet al. Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma57 (5), 1006–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Aurell A , RosengrenLE, KarlssonB, OlssonJE, ZbornikovaV, HaglidKG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke22 (10), 1254–1258 (1991).
   PubMed Web of Science ®Google Scholar
• Foerch C , CurdtI, YanBet al. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J. Neurol. Neurosurg. Psychiatry77 (2), 181–184 (2006).
   PubMed Web of Science ®Google Scholar
• Dvorak F , HabererI, SitzerM, FoerchC. Characterisation of the Diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc. Dis. 27 (1), 37–41 (2009).
   PubMed Web of Science ®Google Scholar
• Cohen SR , BrooksBR, HerndonRM, McKhannGM. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann. Neurol. 8 (1), 25–31 (1980).
   PubMed Web of Science ®Google Scholar
• Matias-Guiu J , Martinez-VazquezJ, RuibalA, ColomerR, BoadaM, CodinaA. Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke. Acta Neurol. Scand73 (5), 461–465 (1986).
   PubMed Web of Science ®Google Scholar
• Jauch EC , LindsellC, BroderickJ, FaganSC, TilleyBC, LevineSR. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Stroke37 (10), 2508–2513 (2006).
   PubMed Web of Science ®Google Scholar
• Bharosay A , BharosayVV, VarmaM, SaxenaK, SodaniA, SaxenaR. Correlation of brain biomarker neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke. Indian J. Clin. Biochem. 27 (2), 186–190 (2012).
   PubMedGoogle Scholar
• Foerch C , MontanerJ, SitzerM, WunderlichM. Elevated serum S100B levels indicate a higher risk of haemorrhagic transformation after thrombolytic therapy in acute stroke. Akt. Neurol. 34 (S 2), P575 (2007).
   Google Scholar
• Tuttolomondo A , Di SciaccaR, Di RaimondoDet al. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J. Neuroimmunol. 215 (1–2), 84–89 (2009).
   PubMed Web of Science ®Google Scholar
• Winbeck K , PoppertH, EtgenT, ConradB, SanderD. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke33 (10), 2459–2464 (2002).
   PubMed Web of Science ®Google Scholar
• Montaner J , MolinaCA, MonasterioJet al. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation107 (4), 598–603 (2003).
   PubMed Web of Science ®Google Scholar
• Castellanos M , LeiraR, SerenaJet al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke34 (1), 40–46 (2003).
   PubMed Web of Science ®Google Scholar
• Lynch JR , BlessingR, WhiteWD, GrocottHP, NewmanMF, LaskowitzDT. Novel diagnostic test for acute stroke. Stroke35, 57–63 (2004).
   PubMed Web of Science ®Google Scholar
• Sotgiu S , ZandaB, MarchettiBet al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur. J. Neurol. 13 (5), 505–513 (2006).
   PubMed Web of Science ®Google Scholar
• Allard L , LescuyerP, BurgessJet al. ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics4 (8), 2242–2251 (2004).
   PubMed Web of Science ®Google Scholar
• Wunderlich MT , HanhoffT, GoertlerMet al. Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke. J. Neurol. 252 (6), 718–724 (2005).
   PubMed Web of Science ®Google Scholar
• Veerkamp JH , ZimmermanAW. Fatty acid-binding proteins of nervous tissue. J. Mol. Neurosci. 16 (2/3), 133–142 (2001).
   PubMed Web of Science ®Google Scholar
• Dambinova SA , KhounteevGA, IzykenovaGA, ZavolokovIG, IlyukhinaAY, SkorometsAA. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49 (10), 1752–1762 (2003).
   PubMed Web of Science ®Google Scholar
• Sato M , SuzukiA, NagataK, UchiyamaS. Increased von Willebrand factor in acute stroke patients with atrial fibrillation. J. Stroke Cerebrovasc. Dis. 15 (1), 1–7 (2006).
   PubMedGoogle Scholar
• Barber M , LanghorneP, RumleyA, LoweGD, StottDJ. d-dimer predicts early clinical progression in ischemic stroke confirmation using routine clinical assays. Stroke37 (4), 1113–1115 (2006).
   PubMed Web of Science ®Google Scholar
• Allard L , BurkhardPR, LescuyerPet al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin. Chem. 51 (11), 2043–2051 (2005).
   PubMed Web of Science ®Google Scholar
• Persson L , HardemarkHG, GustafssonJet al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke18 (5), 911–918 (1987).
   PubMed Web of Science ®Google Scholar
• Anand N , SteadLG. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc. Dis. 20 (4), 213–219 (2005).
   PubMed Web of Science ®Google Scholar
• Casmiro M , MaitanS, DePF, CovaV, ScarpaE, VignatelliL. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Eur. J. Neurol. 12 (5), 369–374 (2005).
   PubMed Web of Science ®Google Scholar
• Dingledine R , BorgesK, BowieD, TraynelisSF. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1), 7–61 (1999).
   PubMed Web of Science ®Google Scholar
• Pelsers MMAL , HanhoffT, vandVDet al. Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin. Chem. 50 (9), 1568–1575 (2004).
   PubMed Web of Science ®Google Scholar
• Licata G , TuttolomondoA, DiRD, CorraoS, DiSR, PintoA. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb. Haemost. 101 (5), 929–937 (2009).
   PubMed Web of Science ®Google Scholar
• Mun-Bryce S , RosenbergGA. Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18 (11), 1163–1172 (1998).
   PubMed Web of Science ®Google Scholar
• Di NM , SchwaningerM, CappelliRet al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP pooling project members. Stroke36 (6), 1316–1329 (2005).
   PubMed Web of Science ®Google Scholar
• Mocco J , ChoudhriTF, MackWJet al. Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery48 (4), 718–721 ; discussion 721–712 (2001).
   PubMed Web of Science ®Google Scholar
• Hoshi T , KitagawaK, YamagamiH, FurukadoS, HougakuH, HoriM. Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis197 (1), 326–332 (2008).
   PubMed Web of Science ®Google Scholar
• Chamorro A , HallenbeckJ. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke37 (2), 291–293 (2006).
   PubMed Web of Science ®Google Scholar
• Moore DF , LiH, JeffriesNet al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke. Circulation111, 212–221 (2005).
   PubMed Web of Science ®Google Scholar
• Tang Y , XuH, DuXet al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J. Cereb. Blood Flow Metab. 26 (8), 1089–1102 (2006).
   PubMed Web of Science ®Google Scholar
• Barr TL , ConleyY, DingJet al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology75, 1009–1014 (2010).
   PubMed Web of Science ®Google Scholar
• Han K-C , YangEG, AhnD-R. Elongated oligonucleotide-linked immunosorbent assay for sensitive detection of a biomarker in a microwell plate-based platform. Biosensors and Bioelectronics50 (0), 421–424 (2013).
   PubMedGoogle Scholar
• de la Rica R , StevensMM. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat. Nano7 (12), 821–824 (2012).
   PubMed Web of Science ®Google Scholar
• Stejskal D , SporovaL, SvestakM, KarpisekM. Determination of serum visinin like protein-1 and its potential for the diagnosis of brain injury due to the stroke: a pilot study. Biomed. Pap. 155 (3), 263–268 (2011).
   PubMed Web of Science ®Google Scholar
• Laterza OF , ModurVR, CrimminsDLet al. Identification of novel brain biomarkers. Clin. Chem. 52 (9), 1713–1721 (2006).
   PubMed Web of Science ®Google Scholar
• Zimmermann-Ivol CG , BurkhardPR, Floch-RohrJL, AllardL, HochstrasserDF, SanchezJ-C. Fatty acid binding protein as a serum marker for the early diagnosis of stroke. Mol. Cell. Proteomics3 (1), 66–72 (2004).
   PubMed Web of Science ®Google Scholar
• Collings FB , VaidyaVS. Novel technologies for the discovery and quantitation of biomarkers of toxicity. Toxicology245 (3), 167–174 (2008).
   PubMed Web of Science ®Google Scholar
• Wang G , HuangH, ZhangG, ZhangX, FangB, WangL. Dual amplification strategy for fabrication of highly sensitive Interleukin-6 amperometric immunosensor based on poly-dopamine. Langmuir27 (3), 1224–1231 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang Y , XuQ, PengQ, CaoZ, WangX, LuJ. Magnetic beads-based chemiluminescence substrate-resolved duplex immunoassay for sequential detection of two ischemic stroke markers with two orders of concentration difference. Anal. Sci. 27, 739–743 (2011).
   PubMed Web of Science ®Google Scholar
• Peng L , WangN, SiH, WuC, ZhangX, YangQ. Rapid and sensitive determination of five amine biomarkers in plasma samples from stroke patients by MEKC with precolumn derivatization. Chromatographia75 (19–20), 1217–1221 (2012).
   Web of Science ®Google Scholar
• Palmer S , WiegandAP, MaldarelliF, BazmiH. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 41, 4531–4536 (2003).
   PubMed Web of Science ®Google Scholar
• Adamski MG , GumannP, BairdAE. A method for quantitative analysis of standard and high-throughput qPCR expression data based on input sample quantity. PLoS One9, e103917 (2014).
   PubMedGoogle Scholar
• Hudson MP , ChristensonRH, NewbyLK, KaplanAL, OhmanEM. Cardiac markers: point of care testing. Clin. Chim. Acta284, 223–237 (1999).
   PubMed Web of Science ®Google Scholar
• Chin CD , LinderV, SiaSK. Commercialization of microfluidic point-of-care diagnostic devices. Lab Chip12, 2118–2134 (2012).
   PubMed Web of Science ®Google Scholar
• Hu J , FerreiraA, Van EldikLJ. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69 (6), 2294–2301 (1997).
   PubMed Web of Science ®Google Scholar
• Parton E , LagaeL, BorghsG. Stroke diagnosis with lab-on-a-chip. Med. Device Technol. 20, 15–17 (2009).
   PubMedGoogle Scholar
• Cima MJ . Microsystem technologies for medical applications. Annu. Rev. Chem. Biomol. Eng. 2, 355–378 (2011).
   PubMed Web of Science ®Google Scholar
• Knauer C , KnauerK, MullerSet al. A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study. BMC Neurol. 12, 14 (2012).
   PubMed Web of Science ®Google Scholar
• Sibon I , RouanetF, MeissnerW, OrgogozoJM. Use of the triage stroke panel in a neurologic emergency service. Am. J. Emerg. Med. 27, 558–562 (2009).
   PubMed Web of Science ®Google Scholar
• Laskowitz DT , KasnerSE, SaverJ, RemmelKS, JauchEC. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke40, 77–85 (2009).
   PubMed Web of Science ®Google Scholar
• Vanni S , PolidoriG, PepeGet al. Use of biomarkers in triage of patients with suspected stroke. J. Emerg. Med. 40, 499–505 (2011).
   PubMed Web of Science ®Google Scholar
• Jackson JM , WitekMA, HupertMLet al. UV activation of polymeric high aspect ratio microstructures: ramifications in antibody surface loading for circulating tumor cell selection. Lab Chip14 (1), 106–117 (2014).
   PubMed Web of Science ®Google Scholar
• Kamande JW , HupertML, WitekMAet al. Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer. Anal. Chem. 85 (19), 9092–9100 (2013).
   PubMed Web of Science ®Google Scholar
• Pullagurla SR , WitekMA, JacksonJMet al. Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis. Anal. Chem. 86 (8), 4058–4065 (2014).
   PubMed Web of Science ®Google Scholar
• Baird AE . Blood biologic markers of stroke: improved management, reduced cost?Curr. Atheroscler. Rep. 8, 267–275 (2006).
   PubMedGoogle Scholar
• Peng Z , YoungB, BairdAE, SoperSA. Single-pair fluorescence resonance energy transfer analysis of mRNA transcripts for highly sensitive gene expression profiling in near real time. Anal. Chem. 85, 7851–7858 (2013).
   PubMed Web of Science ®Google Scholar
• Alison E . BairdDFM, EhudG, KoryJ. WO/2008/008846 (2010).
   Google Scholar
• Group Nr-PSS . Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581–1487 (1995).
   PubMed Web of Science ®Google Scholar